Adult & Pediatric Kidney Transplant Program, Servicio de Urología, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Gregorio Marañón, Universidad Complutense, C/Doctor Esquerdo, 46, 28007, Madrid, Spain.
Curr Urol Rep. 2020 Mar 13;21(2):13. doi: 10.1007/s11934-020-0964-7.
Approximately, 25% of the patients with ESRD will enter the waiting list for kidney transplantation. Among these patients, almost 15% will require a retransplantation surgery. This review aims to summarize the most recent information on different controversial issues regarding retransplantation, to provide the reader with a clear and updated view on the topic.
Despite current evidence is mainly based on retrospective, small, single-center experiences, it seems clear that retransplantation remains a surgical and immunological challenge, for which the perioperative management still remains crucial to avoid mishaps. Different surgical approaches have been tested, but the general consensus advocates for the heterotopic extraperitoneal in first instance. Although higher immunological risk and complication rates are reported invariably in the available series, the benefits in terms of overall survival are superior to those obtained under dialysis, thus still representing the most recommended option for this group of patients.
大约 25%的终末期肾病患者将进入肾脏移植等待名单。在这些患者中,近 15%将需要再次接受移植手术。本篇综述旨在总结有关再次移植的不同争议问题的最新信息,为读者提供关于该主题的清晰、最新的观点。
尽管目前的证据主要基于回顾性的、小型的单中心经验,但很明显,再次移植仍然是一个手术和免疫挑战,围手术期管理对于避免并发症仍然至关重要。已经测试了不同的手术方法,但普遍共识主张首先进行异位腹膜外移植。尽管在现有的系列中不可避免地报告了更高的免疫风险和并发症发生率,但在总体生存率方面的获益优于透析治疗,因此再次成为这群患者最推荐的选择。